US Stock MarketDetailed Quotes

TAK Takeda Pharmaceutical

Watchlist
  • 13.380
  • +0.020+0.15%
Close Apr 23 16:00 ET
  • 13.280
  • -0.100-0.75%
Pre 09:12 ET
42.35BMarket Cap37.06P/E (TTM)

Takeda Pharmaceutical Key Stats

Takeda Pharmaceutical Earnings Date

Currency: JPY

Period

Q3 FY2024 Earnings

Feb 1, 2024

Revenue(YoY)

1.11T

+1.33%
EPS(YoY)

33.44

-11.84%

Buy

Mar 31, 2024

Takeda Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Jul 31, 20242025/Q1-- / 1.038T--
May 9, 20242024/Q4-- / 899.902B--
Feb 1, 20242024/Q31.111T / 1.001T--
Oct 26, 20232024/Q21.043T / 990.336B--
Jul 27, 20232024/Q11.059T / 995.797B--
May 11, 20232023/Q4956.200B / 954.896B--
Feb 2, 20232023/Q31.097T / 996.345B--
Oct 27, 20222023/Q21.002T / 950.078B--
Jul 28, 20222023/Q1972.465B / 953.850B--
May 11, 20222022/Q4873.289B / 848.137B--
DatePeriodRevenue/EstimateEarnings Call
Jul 31, 20242025/Q1-- / 1.038T--
May 9, 20242024/Q4-- / 899.902B--
Feb 1, 20242024/Q31.111T / 1.001T--
Oct 26, 20232024/Q21.043T / 990.336B--
Jul 27, 20232024/Q11.059T / 995.797B--
May 11, 20232023/Q4956.200B / 954.896B--
Feb 2, 20232023/Q31.097T / 996.345B--
Oct 27, 20222023/Q21.002T / 950.078B--
Jul 28, 20222023/Q1972.465B / 953.850B--
May 11, 20222022/Q4873.289B / 848.137B--

Unlock Free Earnings Estimates

Takeda Pharmaceutical Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Buy

  • Buy

    33.33%
  • Hold

    66.67%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg